galena biopharma profile

Galena Biopharma - GALE - Stock Price & News | The Motley Fool

Galena Biopharma Inc is a biotechnology company focused on discovering developing and commercializing innovative therapies addressing major unmet …

No Reasonable Path Forward For Galena Shareholders - Avoid ...

Feb 08, 2017· No Reasonable Path Forward For Galena Shareholders - Avoid. Feb. 8, 2017 11:26 AM ET | ... Galena Biopharma (NASDAQ: ... We see the risk/reward profile of Galena as highly skewed to the downside ...

Galena Biopharma Company Profile - Office Locations ...

Galena Biopharma, Inc. is a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs. The Company's pipeline consists of multiple mid- to late-stage clinical assets, including our hematology asset, GALE-401, and our novel cancer immunotherapy programs including NeuVax (nelipepimut-S), GALE-301 and GALE-302.

Galena Biopharma, Inc. Stockholders Approve Business ...

Dec 29, 2017· Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio ... Galena Biopharma, Inc. ... Profile. Galena Biopharma ...

How Does Galena Biopharma Inc (NASDAQ:GALE) Affect Your ...

Jan 02, 2018· If you are a shareholder in Galena Biopharma Inc's (NASDAQ:GALE), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of …

Final Results of Anagrelide Controlled-Release (GALE-401 ...

Phu V. Troung, Marc Saltzman, Alberto Bessudo, William Jawien, Roger M. Lyons, Dmitriy Berenzon, Raul Mena, Nasiema Wingate-Pearse, Olivier Barriere, Hali E. Beeson, Paul F. Glidden, Gavin S. Choy, Srdan Verstovsek; Final Results of Anagrelide Controlled-Release (GALE-401) Safety, Efficacy and Pharmacokinetics in Subjects with Myeloproliferative Neoplasms (MPN)-Related Thrombocytosis.

GALE - Galena Biopharma In Stock Profile - Barchart.com

Company profile for Galena Biopharma In (GALE) including business summary, key statistics, ratios, sector. ... Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals ...

Galena Biopharma Reviews | Glassdoor

This will replace the current featured review for targeted profile. Are you sure you want to replace it? Cancel Confirm. Are you sure you want to remove this review from being featured for targeted profile? Cancel Confirm. Glassdoor has 4 Galena Biopharma reviews submitted anonymously by Galena Biopharma employees. Read employee reviews and ...

Galena Biopharma Launches Zuplenz® Oral Soluble Film ...

Galena Biopharma Launches Zuplenz® (ondansetron) Oral Soluble Film. Zuplenz is indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) Novel, oral soluble film technology provides convenient delivery and key patient benefits

Galena Biopharma Inc in Portland, OR - (503) 737-0608 ...

Galena Biopharma is located in Portland, Oregon. This organization primarily operates in the Pharmaceutical Preparations business / industry within the Chemicals and Allied Products sector.

Galena Biopharma Inc. - NASDAQ:GALE - Stock Quote & News ...

View detailed financial information, real-time news, videos, quotes and analysis on Galena Biopharma Inc. (NASDAQ:GALE). Explore commentary on Galena Biopharma Inc. and hear what the experts at ...

Working at Galena Biopharma | Glassdoor

Feb 19, 2015· Glassdoor gives you an inside look at what it's like to work at Galena Biopharma, including salaries, reviews, office photos, and more. This is the Galena Biopharma company profile. All content is posted anonymously by employees working at Galena Biopharma.

SLS: Sellas Life Sciences Stock Price - Investing.com

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address ...

SELLAS Life Sciences | Crunchbase

SELLAS Life Sciences is a late-stage biopharmaceutical company. Power your search with Crunchbase Pro . Target the right companies with unlimited search filters, analysis tools, and automatic alerts.

GALENA BIOPHARMA INC : Shareholders Board Members …

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs.

Nicholas J Sarlis, Sellas Life Sciences Group Inc: Profile ...

Nicholas J Sarlis is Former Senior VP/Chief Medical Officer at Sellas Life Sciences Group Inc. See Nicholas J Sarlis's compensation, career history, education, & memberships.

Mark Schwartz - Greater New York City Area | Professional ...

Galena Biopharma 2014 – 2017 3 years. Board Member Bayhill Therapeutics 2011 – 2014 3 years. Skills & Endorsements Join LinkedIn to see Mark's skills, endorsements, and full profile.

Galena Biopharma - Wikipedia

Galena Biopharma (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, and in 2015 moved to San Ramon, California. Mark Schwartz was the company's president and chief executive officer.

GALENA BIOPHARMA Stock Price Today - Markets Insider

Oct 21, 2019· Profile Galena Biopharma MORE SELLAS Life Sciences Group, Inc. operates as a clinical stage biopharmaceutical company, which focuses on …

Galena Biopharma Enters into Merger Agreement with SELLAS ...

About Galena Biopharma. Galena Biopharma, Inc. is a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs. Galena's pipeline consists of multiple mid-to-late-stage clinical assets led by its hematology asset, GALE-401, and its novel cancer immunotherapy programs including NeuVax ...

Requested symbol wasn't found - Yahoo

The requested symbol was not found in our database. Try searching for some other symbol on Yahoo Finance

Galena Biopharma Company Profile: Acquisition & Investors ...

Information on acquisition, funding, investments, investors, and executives for Galena Biopharma. Use the PitchBook Platform to explore the full profile.

GALE Stock Quote - SELLAS Life Sciences Group Inc ...

Stock analysis for SELLAS Life Sciences Group Inc (GALE) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

GALE - Galena Biopharma In Stock Price - Barchart.com

Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals Corporation, is based in Portland, Oregon.

Galena Biopharma (GALE) Stock Message Board - InvestorsHub

Jan 17, 2018· Galena Biopharma (NASDAQ: GALE) is focused on developing and commercializing targeted oncology treatments to address major unmet medical needs and advance cancer care. The company's peptide vaccine immunotherapies harness the patient's own immune system to identify and destroy cancer cells.

About Galena (SLS) - Investing.com

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address ...

About Galena Biopharma (GALE)

Galena Biopharma, Inc. has strategic development and commercialization partnership with Dr. Reddy's Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011.

Galena Biopharma, Inc. - SLS - Stock Price Today - Zacks

View Galena Biopharma, Inc. SLS investment & stock information. Get the latest Galena Biopharma, Inc. SLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Galena Biopharma Company Profile | Markets Insider

Galena Biopharma Company Profile: This is the Company Profile-site for the company Galena Biopharma on Markets Insider. Galena Biopharma Company Profile: This is the Company Profile …

Galena Biopharma Enters into Merger Agreement with SELLAS ...

Aug 08, 2017· Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group ... and elicits CD4 and CD8 immune responses with clinical efficacy and favorable safety profile. ... About Galena ...